UHS CFO Says Hospital Recoveries May Offset 2026 Medicaid Payment Decline

Universal Health Services expects improving performance at three struggling hospitals to help offset a significant decline in nonrecurring Medicaid supplemental payments next year, Chief Financial Officer Steve Filton said at an investor conference.

Three Hospitals Drove Most Losses, Recovery Expected in 2027

  • Three facilities generated between $80 million and $100 million in losses through the third quarter.
  • The company anticipates recovering a meaningful portion of those losses in 2027.
  • Management identified $175 million to $200 million in 2026 Directed Payment Program payments that will not recur.

Hospital Recovery Projections

The San Antonio behavioral facility remains open with a small number of patients while it pursues recertification.

Filton said the company hopes to regain certification sometime in 2027, but the timing remains uncertain. He said the facility generated approximately $25 million to $30 million in 2025.

Nonrecurring Medicaid Payments Offset Next Year's Gains

Filton also expects an approximately $15 million exchange-related headwind next year based on the pace of the decline.

Metric Performance Detail
Adjusted Admissions Rose 4.9% in the third quarter
Emergency Room Visits Increased 4.6% in the third quarter
Problem Facilities Losses Generated $80 million to $100 million through Q3
Nonrecurring Medicaid Offset $175 million to $200 million in 2026 payments

Third-quarter adjusted admissions rose 4.9%, while emergency room visits increased 4.6%.

That differed from the company’s expectation that some patients would obtain other commercial coverage. Universal Health Services increased its estimated impact from the exchange decline to $85 million from $75 million after the second quarter.

Behavioral Health Capital Deployment

Outpatient visits rose 3% in the third quarter, Lehrich said.

Filton expects Talkspace to be modestly accretive through the middle of next year and to help accelerate outpatient growth thereafter.

Filton said share repurchases would at least continue at their current pace.

The company could choose to accelerate repurchases further, he said.

Photo of author

Marina Collins - Entertainment Editor

Senior Editor, Entertainment Marina is a celebrated pop culture columnist and recipient of multiple media awards. She curates engaging stories about film, music, television, and celebrity news, always with a fresh and authoritative voice.

AstraZeneca’s Klygefa Wins US and EU Approval for Myasthenia Gravis

Viking vs Feyenoord Champions League Tickets: Prices & How to Buy